These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28236799)

  • 21. Safe handling of antineoplastic drugs.
    Harrison BR
    Top Hosp Pharm Manage; 1994 Jul; 14(2):1-10. PubMed ID: 10136200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safe handling of hazardous drugs: are you protected?
    Nixon S; Schulmeister L
    Clin J Oncol Nurs; 2009 Aug; 13(4):433-9. PubMed ID: 19648100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NIOSH safe handling of hazardous drugs guidelines becomes state law.
    Eisenberg S
    J Infus Nurs; 2012; 35(5):316-9. PubMed ID: 22955153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing oncology nurses' use of hazardous drug safe-handling precautions.
    Polovich M; Clark PC
    Oncol Nurs Forum; 2012 May; 39(3):E299-309. PubMed ID: 22543401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical approach to assess the hazardous exposure potential of investigational drugs.
    McLeod EN; Fillis CJ; Blind JE
    Am J Health Syst Pharm; 2020 Apr; 77(9):697-700. PubMed ID: 34278414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safe Handling of Hazardous Drugs: ASCO Standards.
    Celano P; Fausel CA; Kennedy EB; Miller TM; Oliver TK; Page R; Ward JC; Zon RT
    J Clin Oncol; 2019 Mar; 37(7):598-609. PubMed ID: 30620670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of occupational safety training effectiveness in healthcare workers].
    Giuliani AR; Panopoulou K; Perrotti A; Paoletti A; Leoni V; Fabiani L
    Ig Sanita Pubbl; 2005; 61(5):451-65. PubMed ID: 17206216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries.
    Mathias PI; MacKenzie BA; Toennis CA; Connor TH
    J Oncol Pharm Pract; 2019 Jan; 25(1):148-162. PubMed ID: 28841099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Summary of recommendations for a rational implementation of the ministry of health guidelines on the prevention of occupational risks in handling antineoplastic agents].
    Gruppo di Lavoro dell'Associazione Italiana di Medicina Preventiva dei Lavoratori della Sanità
    Med Lav; 2001; 92(2):137-48. PubMed ID: 11441591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP <800> and Strategies to Promote Hazardous Drug Safety.
    Eisenberg S
    J Infus Nurs; 2018; 41(1):12-23. PubMed ID: 29293194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing workplace compliance with handling of antineoplastic agents.
    Gambrell J; Moore S
    Clin J Oncol Nurs; 2006 Aug; 10(4):473-7. PubMed ID: 16927900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OSHA safety requirements for hazardous chemicals in the workplace.
    Dohms J
    Radiol Manage; 1992; 14(4):76-80. PubMed ID: 10123093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulations for the protection of workers against the effects of hazardous substances at the workplace].
    Wolf T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Mar; 51(3):266-73. PubMed ID: 18369561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of platinum contamination of a hazardous drug preparation area in a hospital pharmacy].
    Leboucher G; Serratrice F; Bertholle V; Thore L; Bost M
    Bull Cancer; 2002 Nov; 89(11):949-55. PubMed ID: 12495882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hazardous Drugs and USP <800>: Implications for Nurses.
    Eisenberg S
    Clin J Oncol Nurs; 2017 Apr; 21(2):179-187. PubMed ID: 28315550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk communication for protection against hazardous substances in the workplace].
    Pipke R; Wilmes A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 May; 65(5):589-598. PubMed ID: 35403886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing employee apprehension toward handling cytotoxic drugs.
    Moore TD; Hale KM; Cortese LM; Fillmore AD; Jozefczyk KG; Scala SM; Wellman GS
    Am J Hosp Pharm; 1985 Apr; 42(4):826-31. PubMed ID: 4014233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Measures of preventing occupational exposure to hazardous drugs-based on new insights].
    Sugiura S; Gohma H; Hamajima N
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):923-5. PubMed ID: 25132022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the safe handling of hazardous drugs: consensus recommendations.
    Chaffee BW; Armitstead JA; Benjamin BE; Cotugno MC; Forrey RA; Hintzen BL; Pfeiffenberger T; Stevenson JG
    Am J Health Syst Pharm; 2010 Sep; 67(18):1545-6. PubMed ID: 20811033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.